glp-1 news today 2025 november 6 🚨 Breaking in Obesity Care! 🚨 President Trump just announced major deals with Eli Lilly and Novo Nordisk — the makers of Mounjaro, Zepbound, Wegovy, and Ozempic — to slash weight ISPOR 2025: Exploring reasons for

[DOI] [PMC free article] [PubMed] [Google Scholar] 33.Ceriello A., Esposito K., Testa R., Bonfigli A.R., Marra M., Giugliano D

it does not endorse probiotics as treatment for non-specific bloating or gut discomfort

Someone stopping these medications doesnt have the same control over their obesity, and their weight can increase. What to expect Nearly 12% of Americans about one in eight have used GLP-1 drugs for weight loss, according to a 2025 report from RAND, a nonprofit research organization

Kueper J, Beyth S, Liebergall M, Kaplan L, Schroeder JE

For weight management specifically, the FDA has approved several GLP-1 medications at higher doses than those used for diabetes treatment